HMGB1 and ischemic stroke: HMGB1 participates in blood–brain barrier disruption and inflammatory response, and its potential as a therapeutic target for mitigating post-ischemic stroke complications such as hemorrhagic transformation after thrombolysis or infection needs to be explored.